Q2 2025 Holdings
Filed 2025-08-14 | 23 holdings | $799.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $194.1M | 10,719,110 | 24.3% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $121.8M | 2,500,680 | 15.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $110.4M | 1,447,267 | 13.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $58.1M | 3,303,381 | 7.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $46.2M | 2,482,250 | 5.8% |
| Savara Inc(SVRA) | COM | 805111101 | $40.1M | 17,600,621 | 5.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $38.5M | 7,911,669 | 4.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $30.9M | 583,500 | 3.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $29.2M | 6,843,954 | 3.6% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $29.1M | 8,434,560 | 3.6% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $26.8M | 2,439,538 | 3.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $14.7M | 9,677,125 | 1.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $13.9M | 2,712,008 | 1.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.6M | 5,249,069 | 1.6% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $10.3M | 3,368,370 | 1.3% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $8.9M | 2,485,638 | 1.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $3.1M | 4,566,817 | 0.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.0M | 5,410,361 | 0.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.6M | 8,663,673 | 0.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.6M | 1,111,910 | 0.2% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $1.3M | 1,799,595 | 0.2% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $1.1M | 563,859 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $800.0K | 100,000 | 0.1% |